Member Info for Kingalf

IMHO they are softening the blow of negative news on the STAR trial by releasing positive news on either side of that announcement.

Moneymunch you've certainly built a fan base on both sites, they all seem to lap up what you offer and ask for more. Clearly feeding their hopes because let's face it that's really all they have when it comes to Evgen.
I'm wondering how popular you'll be in a few weeks when the price hits 3p.

Made my 20% and I'm out of these again.
Good luck to the rest of you

Not entirely sure why these are registered as buys when infact they are sales (apart from 8.96)

26-May-21 11:06:38 8.811 11,486 Buy* 1,012 O
26-May-21 11:04:13 8.96 2,745 Buy* 245.95 O
26-May-21 10:44:12 8.80 200,000 Buy* 17.60k O
26-May-21 10:43:49 8.811 42,000 Buy* 3,701 O
26-May-21 10:43:46 8.811 10,000 Buy* 881.10 O

On a positive note the price is holding up quite well considering.

Let's not forget Juvenescence, we still have $10.5 million due within the next 12 months.

Thank you for the tip

Interesting article in the ft today regarding supermarkets.
Terry Smith doesn't seem to be a fan but others are more hopeful.

Terry Smith, one of the UK’s most successful fund managers, said the sector still had unattractive characteristics, including margins so thin that “every bump in the road is potentially very painful”.

“They also make very low returns on capital, significantly below their cost of capital, which in the long run is disastrous,” he said, adding that many of the benefits of restructuring had flowed to customers in the form of lower prices.

“Over time they have started to resemble utilities funded by shareholders for the benefit of consumers,” Smith said. “To paraphrase the late great Sir Brian Pitman, sometimes some markets don’t produce any winners.”

Interesting article in the ft today regarding supermarkets.
Terry Smith doesn't seem to be a fan but others are more hopeful.

Terry Smith, one of the UK’s most successful fund managers, said the sector still had unattractive characteristics, including margins so thin that “every bump in the road is potentially very painful”.

“They also make very low returns on capital, significantly below their cost of capital, which in the long run is disastrous,” he said, adding that many of the benefits of restructuring had flowed to customers in the form of lower prices.

“Over time they have started to resemble utilities funded by shareholders for the benefit of consumers,” Smith said. “To paraphrase the late great Sir Brian Pitman, sometimes some markets don’t produce any winners.”

Interesting article in the ft today regarding supermarkets.
Terry Smith doesn't seem to be a fan but others are more hopeful.

Terry Smith, one of the UK’s most successful fund managers, said the sector still had unattractive characteristics, including margins so thin that “every bump in the road is potentially very painful”.

“They also make very low returns on capital, significantly below their cost of capital, which in the long run is disastrous,” he said, adding that many of the benefits of restructuring had flowed to customers in the form of lower prices.

“Over time they have started to resemble utilities funded by shareholders for the benefit of consumers,” Smith said. “To paraphrase the late great Sir Brian Pitman, sometimes some markets don’t produce any winners.”

This is where Dr Kuhlman could well prove a good appointment with her experience in government funding and equity investment.

Seems the end of day selling has been replaced by early morning selling.
Still they have a strong team in place, lots of potential to do some partnership deals.
They have the equivalent of at least 4p share price equivalent in cash.
10 million $ due in the next 18 months so shouldn't really be any further placements.
Even if the STAR trial is a dud, there is a lot to keep the interest bubbling.

This would normally be a positive sign and I would be highlighting it, but market markets are known to artificially create such patterns to suck in the buyers. IMHO I think they have done just that, the trade at 7.8p on Friday was for just £78 and this was needed to create the hammer. Buy when your ready not when the market makers want you to.

I could be a little premature, but the end of day crazie selling seems to have stopped.
Could they finally have finished ????

Inflammatory drugs seem to be the way forward.
Negative news on the STAR trial will probably see the share price down to around 3.5p, anything positive will finally see this rocket. From a risk reward perspective its worth a punt IMHO.

Drug discovery group C4X Discovery Holdings surged after announcing that its subsidiary had signed an exclusive worldwide licensing agreement with French pharma multinational Sanofi, worth up to €414m, to develop and commercialise an oral therapy for the treatment of inflammatory diseases.

“This licence is a validation of the C4XD business model, showing the significant value in early-stage programmes,” said Julie Simmonds, an analyst at Panmure Research, who reiterated her “buy” recommendation.

The deal shifted the cost of this particular project to Sanofi, “giving C4XD more cash to both invest in its existing programmes and also start to scale up development of the next generation of programmes”.

Could well test the 200 day moving Average in the next week.
I'm expecting the spread betting to pick up which will give it a boost.

200-Day Moving Average 10.47
50-Day Moving Average 8.80
20-Day Moving Average 7.87
10-Day Moving Average 7.74

The problem we have here is that on previous good news the shares have sold off, this is keeping a cap on these IMHO.
This time it's different, placement is out of the way, strong management, plenty of cash and very favorable news on the horizon.
If there was ever a good time to buy, this would be it, any sell off should be a great buying opportunity IMHO.

Looks like we have a Hammer reversal pattern formed on the candle sticks today.
Should see some upside from here.
Chart points to aim for
200-Day Moving Average 10.54;
50-Day Moving Average 9.05;
20-Day Moving Average 7.92;
10-Day Moving Average 7.78;

At the end of the day they seem to have a strong management team, not sure if some of the appointments were necessary at this stage, and a solid cash base which will only strengthen when they receive the 10.5m $$ in the next year or so. There is minimal upside priced into these, admittedly I'm sitting at a good level having just gone in again, but I do feel for the long term investors who have loyally stuck with this. Hopefully your commitment will be rewarded.